Jake D. Fanizza, BS (he/him/his)

Drexel University College of Medicine

Poster(s):

• P3761 - SGLT-2 Inhibitors Are Associated With Lower Risk of Hepatic Decompensation in Metabolic Dysfunction Associated Steatotic Liver Disease: Real-World Evidence
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT